ArticleTherapeutic advances in drug safety2018
The hope, hype and reality of Big Data for pharmacovigilance.
Article in Therapeutic advances in drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- Part 1 - imidazolines and the changing face of nasal decongestants.Frontiers in pharmacology · 2025Review
- Sample Bias in Web-Based Patient-Generated Health Data of Dutch Patients With Gastrointestinal Stromal Tumor: Survey Study.JMIR formative research · 2022Article
- Article
- Engaging PatientsFrontiers in pharmacology · 2022Article
- Identifying Actionability as a Key Factor for the Adoption of 'Intelligent' Systems for Drug Safety: Lessons Learned from a User-Centred Design Approach.Drug safety · 2021Article
- Big data, medicines safety and pharmacovigilance.Journal of pharmaceutical policy and practice · 2021Article
- Article
- Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project.Drug safety · 2020Article
- Adverse Drug Reaction Case Safety Practices in Large Biopharmaceutical Organizations from 2007 to 2017: An Industry Survey.Pharmaceutical medicine · 2019Article
- Data Science for Child Health.The Journal of pediatrics · 2019Review
- From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data.Drug safety · 2019Article
- How Clinical Practice Research Datalink data are used to support pharmacovigilance.Therapeutic advances in drug safety · 2019Review
- Hypothesis-free signal detection in healthcare databases: finding its value for pharmacovigilance.Therapeutic advances in drug safety · 2019Article
- Factors that influence the intention to use mobile phone caller tunes for patient reporting of adverse drug reactions: a qualitative study.Therapeutic advances in drug safety · 2019Article
- Medicines in pregnancy.F1000Research · 2019Review
- Comment on "Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project".Drug safety · 2018Article
- Temporal Poisson Square Root Graphical Models.Proceedings of machine learning research · 2018Article
- Crowdsourcing sugammadex adverse event rates using an in-app survey: feasibility assessment from an observational study.Therapeutic advances in drug safety · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.